[HTML][HTML] Mini-ALPPS-based multidisciplinary treatment leading to long-term survival in a patient with a large HCC: A case report

GM Liu, YM Zhang - Frontiers in Surgery, 2023 - frontiersin.org
Background The future liver remnant (FLR) induced by stage I associated liver partition and
portal vein ligation for staged hepatectomy (ALPPS) in hepatocellular carcinoma (HCC) …

The ALPPS in the Treatment of Hepatitis B–Related Hepatocellular Carcinoma With Cirrhosis: A Single-Center Study and Literature Review

X Cai, Y Tong, H Yu, X Liang, Y Wang… - Surgical …, 2017 - journals.sagepub.com
Background. Associating liver partition and portal vein ligation for staged hepatectomy
(ALPPS) has been reported to be a new treatment strategy for patients with predicted small …

[HTML][HTML] Case report: hepatic artery infusion chemotherapy after stage I ALPPS in a patient with huge HCC

W Zhuo, A Li, W Yang, J Duan, J Min, J Wei - Frontiers in Surgery, 2021 - frontiersin.org
Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can
induce rapid hypertrophy of the liver remnant. However, with a background of liver cirrhosis …

[HTML][HTML] Salvage transhepatic arterial embolization after failed stage I ALPPS in a patient with a huge HCC with chronic liver disease: a case report

Z Wang, Y Peng, Q Sun, X Qu, M Tang, Y Dai… - International journal of …, 2017 - Elsevier
Introduction The degree of hypertrophy of the future liver remnant (FLR) induced by
associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in …

Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single …

V Lazarou, D Dervenis, C Charalambous… - European Journal of …, 2019 - ejso.com
Background: The ALPPS approach allows obtaining resectability of extensive hepatic
malignancies by a rapid and large future liver remnant (FLR) hypertrophy. In several series …

Associating liver partition and portal vein ligation for staged hepatectomy offers high oncological feasibility with adequate patient safety: a prospective study at a single …

FA Alvarez, V Ardiles, M de Santibañes, J Pekolj… - Annals of …, 2015 - journals.lww.com
Objective: To determine the safety, feasibility, and efficacy of associating liver partition and
portal vein ligation for staged hepatectomy (ALPPS) in a single high-volume hepatobiliary …

[HTML][HTML] Associating liver partition and portal vein ligation for a patient with hepatocellular carcinoma with a background of hepatitis B related fibrotic liver

NH Chia, ECH Lai, WY Lau - International Journal of Surgery Case Reports, 2014 - Elsevier
INTRODUCTION Associating liver partition and portal vein ligation for staged hepatectomy
(ALPPS) has recently been developed for patients with predicted insufficient future liver …

[HTML][HTML] Partial ALPPS with a longer wait between procedures is safe and yields adequate future liver remnant hypertrophy

N Kumar, T Duncan, D O'Reilly… - Annals of Hepato …, 2019 - synapse.koreamed.org
Backgrounds/Aims Associating Liver Partition and Portal Vein Ligation for Staged
Hepatectomy (ALPPS) has generated controversy due to high morbidity and mortality. We …

[HTML][HTML] Clinical evaluation of modified ALPPS procedures based on risk-reduced strategy for staged hepatectomy

J Li, GS Yang, KJ Sun, Y Ma, XW Bi, X Han - Annals of Hepatology, 2021 - Elsevier
Abstract Introduction and Objectives Radical resection remains the only curative treatment
for liver tumors. Although associating liver partition and portal vein ligation for staged …

[HTML][HTML] Application of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma related to hepatitis B virus: comparison …

J Zhang, Y Xu, H Yang, H Huang, J Bian… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background Associating liver partition and portal vein ligation for staged hepatectomy
(ALPPS) has recently been suggested to cause rapid liver hypertrophy among patients …